Empowered Patient Podcast

Kurt Workman, Co-Founder and CEO, Owlet describes a digital healthcare platform for parents of infants that is part of a connected nursery ecosystem providing critical and reassuring real-time and archived data about the baby. The pulse oximetry technology in their anchor product Smart Sock allows parents to track the baby's heart rate, oxygen levels, information about movement, sleep quality and skin temperature and notifies the parent in real-time if they need to check on the baby. This new source of data about babies, once they have left the hospital and are home, is being used by researchers to study infant cardiac issues and high risk as well as presumably healthy babies.

@owletbabycare #newparent #newdad #newmom #baby #babyregistry #sleeptraining #digitalhealth

OwletCare.com

Listen to the podcast here

Kurt Workman, Co-Founder and CEO, Owlet describes a digital healthcare platform for parents of infants that is part of a connected nursery ecosystem providing critical and reassuring real time and archived data about the baby. The pulse oximetry technology in their anchor product Smart Sock allows parents to track the baby's heart rate, oxygen levels, information about movement, sleep quality and skin temperature and notifies the parent in real-time if they need to check on the baby. This new source of data about babies, once they have left the hospital and are home, is being used by researchers to study infant cardiac issues and high risk as well as presumably healthy babies.

@owletbabycare #newparent #newdad #newmom #baby #babyregistry #sleeptraining #digitalhealth

OwletCare.com

Download the transcript here

Luke Smith, Client Operations Analyst, Central Logic and the Director of the Arizona Surge Line finally has time to reflect on the work that went into managing access to hospitals and post-acute care for patients suffering from COVID-10 throughout the state of Arizona, at one point the number 1 hot spot in the world for positivity. The Surge Line Access Center worked with public and private organizations to expeditiously transfer patients from a diverse population to the level of care they needed as well as get them back home safely.

@CentralLogic #HealthSystems #PatientOutcomes #HealthIT #PublicHealth #Arizona #COVID19 #RevenueCapture #ClinicianEffectiveness #Hospitals #BedVisibility #PatientExperience

CentralLogic.com

Listen to the podcast here.

Luke Smith, Client Operations Analyst, Central Logic and the Director of the Arizona Surge Line finally has time to reflect on the work that went into managing access to hospitals and post-acute care for patients suffering from COVID-10 throughout the state of Arizona, at one point the number 1 hot spot in the world for positivity. The Surge Line Access Center worked with public and private organizations to expeditiously transfer patients from a diverse population to the level of care they needed as well as get them back home safely.

@CentralLogic #HealthSystems #PatientOutcomes #HealthIT #PublicHealth #Arizona #COVID19 #RevenueCapture #ClinicianEffectiveness #Hospitals #BedVisibility #PatientExperience

CentralLogic.com

Download the transcript here.

Amy Grover, Director of Patient Advocacy, Catalyst Pharmaceuticals works primarily with patients suffering from Lambert-Eaton Myasthenic Syndrome LEMS an ultra-rare disease which is very similar to a larger rare disease myasthenia gravis MG. Working with the patient community and patient advocacy groups, Catalyst is providing support, tools and resources that for the most part have moved online during the pandemic. As a seasoned patient advocate, Amy is aware of how unique each patient's journey is and how important their participation is in driving research.

@CatalystForRare #RareReason #rarediseases #LEMS #MG #patientadvocate

CatalystPharma.com

Listen to the podcast here

Amy Grover, Director of Patient Advocacy, Catalyst Pharmaceuticals works primarily with patients suffering from Lambert-Eaton Myasthenic Syndrome LEMS an ultra-rare disease which is very similar to a larger rare disease myasthenia gravis MG. Working with the patient community and patient advocacy groups, Catalyst is providing support, tools and resources that for the most part have moved online during the pandemic. As a seasoned patient advocate, Amy is aware of how unique each patient's journey is and how important their participation is in driving research.

@CatalystForRare #RareReason #rarediseases #LEMS #MG #patientadvocate

CatalystPharma.com

Download the transcript

Sally Embrey, Vice President Public Health and Health Tech, DataRobot is applying knowledge from work as an enterprise AI company to attacking the problem of containing and defeating COVID-19. ContagionNET was created to identify leading and lagging indicators of the next COVID-19 hotspot and to help people understand their status, risk and ability to spread the disease. Combining science, testing data and AI-based technology, models have been created and used by NIH, HHS, FDA and other partners to better allocate resources, recruit for vaccine trials, and make more accurate long-term forecasts.

@ContagionNET #DataRobot #COVID19 #pandemic #NIH #PopulationHealth #AI #VaccineTrials #COVIDHotSpots

DataRobot.com

Listen to the podcast here

Sally Embrey, Vice President Public Health and Health Tech, DataRobot is applying knowledge from work as an enterprise AI company to attacking the problem of containing and defeating COVID-19. ContagionNET was created to identify leading and lagging indicators of the next COVID-19 hotspot and to help people understand their status, risk and ability to spread the disease. Combining science, testing data and AI-based technology, models have been created and used by NIH, HHS, FDA and other partners to better allocate resources, recruit for vaccine trials, and make more accurate long-term forecasts.

@ContagionNET #DataRobot #COVID19 #pandemic #NIH #PopulationHealth #AI #VaccineTrials #COVIDHotSpots

DataRobot.com

Download the transcript here

Dr. Stephen Brannan, Chief Medical Officer, Karuna Therapeutics discusses the need for creating and delivering transformative medicines for people living with psychiatric and neurological conditions particularly schizophrenia. Pairing the muscarinic agonist with a pan-cholinergic antagonist that does not cross into the central nervous system, KarXT is mitigating the peripheral side effects like weight gain and sedation but still retaining the benefits from muscarinic agonist.

@KarunaPharma $KRTX #NeuroTwitter #CNS #schizophrenia #schizoprenia #Neuroscience

KarunaTX.com

Listen to the podcast here

Dr. Stephen Brannan, Chief Medical Officer, Karuna Therapeutics discusses the need for creating and delivering transformative medicines for people living with psychiatric and neurological conditions particularly schizophrenia. Pairing the muscarinic agonist with a pan-cholinergic antagonist that does not cross into the central nervous system, KarXT is mitigating the peripheral side effects like weight gain and sedation but still retaining the benefits from muscarinic agonist.

@KarunaPharma $KRTX #NeuroTwitter #CNS #schizophrenia #schizoprenia #Neuroscience

KarunaTX.com

Download the transcript here